Albert David LtdPharmaceuticalsINE155C01010Standalone₹847.25-1.50 (-0.18%)Jun-26
Valuation
Market Cap₹475.75 Cr
TTM PE21.09x
Forward PE13.80x
PEG-0.01
Book Value₹686.05
P/B1.22x
TTM EPS₹39.53
Fwd EPS₹60.43
TTM Revenue₹364.37 Cr
TTM PAT₹22.57 Cr
TTM EBITDA₹26.77 Cr
TTM EBIT₹17.11 Cr
Last Qtr PAT₹32.00 Cr
Last Qtr EBITDA₹10.65 Cr
Last Qtr EBIT₹8.36 Cr
Profitability
ROE5.76%
ROCE7.00%
TTM NPM6.19%
TTM EBITDA %7.35%
Curr OPM24.75%
Last OPM-35.11%
Curr NPM—
Last NPM—
Curr EPS₹56.07
Last EPS₹-37.56
Balance sheet
Equity₹5.71 Cr
Reserve₹385.83 Cr
Total Debt₹28.48 Cr
D/E0.07x
Interest %1.63%
Curr Interest₹0.52 Cr
Price / range
Close₹833.60
vs 52W High-10.54%
vs 52W Low+43.40%
MA50—
MA200—
Returns
1D-0.58%
1W+0.13%
1M+1.49%
3M+19.34%
6M+25.70%
1Y+3.02%
2Y-43.05%
3Y+9.91%
5Y+40.38%
Diwali+12.65%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 1 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits